COMITÉ DIRECTIVO DEL DMT
Lana Castellucci, MD, FRCPC, MSc
Assistant Professor, Faculty of Medicine
University of Ottawa
The Ottawa Hospital Research Institute
Dr. Lana Castellucci is an Assistant Professor in the Faculty of Medicine at the University of Ottawa, and an Associate Scientist at The Ottawa Hospital Research Institute. She sits on the Board of Directors of Thrombosis Canada, a national organization promoting patient education and improved outcomes for patients with venous thrombosis. She is an active member of the CanVECTOR (Canadian Venous Thromboembolism Clinical Trials and Outcomes Research) Network, and recipient of the Heart and Stroke Foundation of Canada National New Investigator Award.
Dr. Castellucci's clinical and research interests are focused on the prevention, diagnosis and management of anticoagulant-related bleeding and venous thromboembolism. She is the Principal Investigator of a peer-reviewed international clinical trial (funded by the Canadian Institutes of Health Research) Comparison of Bleeding Risk between Rivaroxaban and Apixaban (COBRRA) in patients with acute venous thromboembolism.
Follow Dr. Castellucci on Twitter at @LanaCastellucci.